September 29, 2014
Providence Medical Technology, Inc. today announced that the U.S. Patent and Trademark Office issued patents 8,834,530, Cervical Distraction Method; 8,834,472, Vertebral Joint Implants and Delivery Tools, and 8,828,062, Vertebral Joint Implants and Delivery Tools to the company in September 2014.
July 1, 2014
Providence Medical Technology, Inc. announced today it has closed a $3 million venture debt agreement with East West Bank. The debt facility complements the $6.8 million venture funding that closed earlier in 2014.
March 31, 2014
Providence Medical Technology, Inc. today announced that it has closed a $6.8 million Series C round of financing. Stanmore Medical Investments led the round through its MedVest Fund One, and was joined by Aphelion Capital and RCT Ventures.
October 21, 2013
Providence Medical Technology, Inc. (PMT) today announced that two‐year follow‐up data on patients treated with the DTRAX Facet System will be available in the electronic poster session at the Congress of Neurological Surgeons (CNS) Annual Meeting in San Francisco, October 19‐23. This data represents follow‐up to the one‐year results published earlier in 2013 in the Journal of Neurosurgery: Spine.
January 13, 2013
Providence Medical Technology, Inc. (PMT) today announced that five U.S. patents have been issued in the past 12 months protecting the DTRAX® family of technologies, bringing the total number of U.S. patents issued to the company by the U.S. Patent Office to seven.